Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 19, Pages 10271
Publisher
MDPI AG
Online
2021-09-25
DOI
10.3390/ijms221910271
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation
- (2021) Soon Kyu Lee et al. Hepatology International
- Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation?
- (2021) Seham A. Omar et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma
- (2021) Jingjing Guo et al. Oncology Letters
- Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
- (2021) Incheon Kang et al. Clinical and Molecular Hepatology
- Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review
- (2020) Thibaut d’Izarny‐Gargas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma
- (2020) Hana Park et al. Hepatology International
- Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
- (2020) Gustavo Ferrín et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of a Serum Tumor Marker‐Based Recurrence Prediction Model after Radiofrequency Ablation for Hepatocellular Carcinoma
- (2020) Jeongin Yoo et al. LIVER INTERNATIONAL
- Optimizing curative management of hepatocellular carcinoma
- (2020) Pierre Nahon et al. LIVER INTERNATIONAL
- Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria
- (2020) Diamantis I. Tsilimigras et al. ANNALS OF SURGICAL ONCOLOGY
- Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: a Systematic Review
- (2020) Vincent L. Chen et al. Clinical Gastroenterology and Hepatology
- IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
- (2020) Stephen P Hack et al. Future Oncology
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients
- (2020) Dan G. Duda et al. Cancers
- Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
- (2020) Matthias Pinter et al. GUT
- Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
- (2020) Gaia Giannone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article
- (2020) Mohamad Mouchli et al. Annals of Hepatology
- Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma
- (2020) Katharina Leuchte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy
- (2020) Keyur Patel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
- (2020) Matthias Pinter et al. JAMA Oncology
- Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
- (2020) Francesco Tovoli et al. Vaccines
- Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
- (2020) Jihye Kim et al. Clinical and Molecular Hepatology
- Long-term prognosis and management of hepatocellular carcinoma after curative treatment
- (2020) Naoshi Nishida Clinical and Molecular Hepatology
- Are There Upper Limits in Tumor Burden for Down-staging of HCC to Liver Transplant? Analysis of the All-comers Protocol
- (2019) Jasmine Sinha et al. HEPATOLOGY
- Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation
- (2019) Yeon-koo Kang et al. EUROPEAN RADIOLOGY
- Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy
- (2019) Zachary J. Brown et al. HEPATOLOGY
- Bridging Hepatocellular Carcinoma to Transplant: Transarterial Chemoembolization Response, Tumor Biology, and Recurrence after Transplantation in a 12-Year Transplant Cohort
- (2019) Tyler Sandow et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
- (2019) Noha Abdel-Wahab et al. Journal for ImmunoTherapy of Cancer
- Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection
- (2019) Zheng-Jun Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
- (2019) Carolina Boni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
- (2019) Qianwei Ye et al. Molecular Cancer
- Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
- (2019) Etienne Buscail et al. Molecular Oncology
- Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
- (2019) Kostandinos Sideras et al. Scientific Reports
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Liver transplantation for hepatocellular carcinoma: Management after the transplant
- (2019) Elizabeth C. Verna et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma
- (2018) CHOONG-KYUN NOH et al. ANTICANCER RESEARCH
- Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study
- (2018) Neil Mehta et al. Clinical Gastroenterology and Hepatology
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma
- (2018) Xiang Jing et al. Journal of Cancer Research and Therapeutics
- Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
- (2018) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Use of checkpoint inhibitors in liver transplant recipients
- (2018) Stefan Munker et al. United European Gastroenterology Journal
- Combinations of Bevacizumab With Cancer Immunotherapy
- (2018) Daniel S. Chen et al. CANCER JOURNAL
- Liquid biopsy for liver diseases
- (2018) Jelena Mann et al. GUT
- Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
- (2018) Anthony W.H. Chan et al. JOURNAL OF HEPATOLOGY
- Epidemiology and Management of Hepatocellular Carcinoma
- (2018) Laura Kulik et al. GASTROENTEROLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Circulating CD14+ HLA-DR−/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery
- (2017) Xing-Hui Gao et al. HEPATOLOGY RESEARCH
- Effects of microwave ablation on T-cell subsets and cytokines of patients with hepatocellular carcinoma
- (2017) Haiwen Zhang et al. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
- Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
- (2017) Priti S. Hegde et al. SEMINARS IN CANCER BIOLOGY
- Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma
- (2017) Xiaomeng Dai et al. Translational Oncology
- Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict microvascular invasion in patients with hepatocellular carcinoma
- (2017) Yanlong Yu et al. Oncotarget
- Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
- (2017) Neil Mehta et al. JAMA Oncology
- Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria
- (2016) Jeong-Hoon Lee et al. ANNALS OF SURGERY
- Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection
- (2016) Yan Zhou et al. BMC CANCER
- Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
- (2016) Julien Calderaro et al. HEPATOLOGY
- Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction
- (2016) Xiao-Lei Shi et al. JOURNAL OF HEPATOLOGY
- Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation
- (2016) Chien-Chin Hsu et al. TRANSPLANTATION
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
- (2016) Davide Citterio et al. JAMA Surgery
- Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- (2016) A. Gabrielson et al. Cancer Immunology Research
- Recurrence of Hepatocellular Cancer After Resection
- (2015) Parissa Tabrizian et al. ANNALS OF SURGERY
- Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma
- (2015) Gi Hong Choi et al. ANNALS OF SURGICAL ONCOLOGY
- Surgical Resection and Liver Transplantation for Hepatocellular Carcinoma
- (2015) Mohamed E. Akoad et al. Clinics in Liver Disease
- Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
- (2015) Francis Y. Yao et al. HEPATOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation
- (2015) Roongruedee Chaiteerakij et al. LIVER TRANSPLANTATION
- Prognostic value of18F-FDG PET/CT in liver transplantation for hepatocarcinoma
- (2015) Olivier Detry WORLD JOURNAL OF GASTROENTEROLOGY
- Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report
- (2015) Rui Liao et al. World Journal of Surgical Oncology
- Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation
- (2014) Wei Zhang et al. LIVER TRANSPLANTATION
- Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria
- (2014) Bilal Hameed et al. LIVER TRANSPLANTATION
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
- (2013) S. Kalathil et al. CANCER RESEARCH
- Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
- (2013) Carlo Sposito et al. JOURNAL OF HEPATOLOGY
- ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
- (2013) Marianne Ziol et al. JOURNAL OF HEPATOLOGY
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
- (2013) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ⩽3cm. Results of a multicenter Italian survey
- (2013) Maurizio Pompili et al. JOURNAL OF HEPATOLOGY
- 11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon's Perspective
- (2013) T. T. Cheung et al. JOURNAL OF NUCLEAR MEDICINE
- Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
- (2013) Dong Ho Lee et al. RADIOLOGY
- Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
- (2013) Shun-Jun Fu et al. SURGERY
- Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis
- (2013) Matteo Cescon WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
- (2012) K. V. Menon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Foxp3-positive Tumor-infiltrating Lymphocytes in the Histologic Features and Clinical Outcomes of Hepatocellular Carcinoma
- (2012) Alka Mary Mathai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Role of the PD-1 Pathway in the Immune Response
- (2012) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- Impairment of CD4+cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma
- (2012) Junliang Fu et al. HEPATOLOGY
- Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
- (2012) Yun-Fan Sun et al. HEPATOLOGY
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
- (2012) Eishiro Mizukoshi et al. HEPATOLOGY
- Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma
- (2012) Alpna R. Limaye et al. HEPATOLOGY RESEARCH
- Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells
- (2012) Maciej Bogdan Maniecki et al. INTERNATIONAL JOURNAL OF CANCER
- Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome
- (2012) Manuel Rodríguez-Perálvarez et al. JOURNAL OF HEPATOLOGY
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
- (2012) Takashi Motomura et al. JOURNAL OF HEPATOLOGY
- Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors
- (2012) Young-sun Kim et al. JOURNAL OF HEPATOLOGY
- Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma
- (2012) Ho Jung An et al. LIVER TRANSPLANTATION
- Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA
- (2012) Jian Kong et al. PLoS One
- 18F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma
- (2012) Seung Duk Lee et al. TRANSPLANT INTERNATIONAL
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
- (2011) Shuichiro Shiina et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
- (2011) A. van de Stolpe et al. CANCER RESEARCH
- Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1α, VEGF, and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma
- (2011) Zuo-Lin Xiang et al. CLINICAL CANCER RESEARCH
- Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes
- (2011) Tetsuya Nakatsura INTERNATIONAL JOURNAL OF ONCOLOGY
- Ubiquitin-specific Protease 19 (USP19) Regulates Hypoxia-inducible Factor 1α (HIF-1α) during Hypoxia
- (2011) Mikael Altun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- m-TOR inhibitors: What role in liver transplantation?
- (2011) Toshiyasu Kawahara et al. JOURNAL OF HEPATOLOGY
- Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
- (2011) Vincenzo Mazzaferro et al. LIVER TRANSPLANTATION
- Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
- (2011) Wenhua Liang et al. LIVER TRANSPLANTATION
- Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
- (2011) Kaoru Tsuchiya et al. ONCOLOGY
- Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
- (2011) Zhen Zeng et al. PLoS One
- Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers
- (2011) Valentina Rosa Bertuzzo et al. TRANSPLANTATION
- Radiofrequency Ablation of Hepatocellular Carcinoma: Pros and Cons
- (2010) Hyunchul Rhim et al. Gut and Liver
- Tumor-Activated Monocytes Promote Expansion of IL-17-Producing CD8+ T Cells in Hepatocellular Carcinoma Patients
- (2010) D.-M. Kuang et al. JOURNAL OF IMMUNOLOGY
- Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma
- (2010) Jae Min Chun et al. JOURNAL OF SURGICAL ONCOLOGY
- Peritumoral Activated Hepatic Stellate Cells Predict Poor Clinical Outcome in Hepatocellular Carcinoma After Curative Resection
- (2009) Min-Jie Ju et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma
- (2009) M. Fujiki et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma
- (2009) Karim J. Halazun et al. ANNALS OF SURGERY
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
- (2009) Sasan Roayaie et al. GASTROENTEROLOGY
- Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors
- (2008) Marco Vivarelli et al. ANNALS OF SURGERY
- Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies
- (2008) Yun Ku Cho et al. HEPATOLOGY
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
- (2008) Kenichi Hakamada et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma
- (2007) A. Sasaki et al. EJSO
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now